Therefore, this mass-spectrometry-based approach seemed the most effective method for gaining new insight into the function of CXCL12 on CLL cell survival and possibly disease aggressiveness. This evidence concerns the gene CXCL12 and B-cell chronic lymphocytic leukemia.